If you have not had labs in more than 3 months, get fresh ones before your first tirzepatide injection
Retatrutide is a synthetic triple receptor agonist activating GLP-1, GIP, and glucagon receptors simultaneously, studied as a next-generation metabolic research compound
this review covers the GLPatch transdermal patch from glpatch.shop only Delivery method: Transdermal - skin-applied, not swallowed Brand-stated mechanism: "Bypasses the digestive tract" through direct skin absorption
The following are some of the common side effects of Tirzepatide: Nausea Vomiting Diarrhea Abdominal Pain Appetite Loss Headache Fatigue Dizziness Constipation Upset Stomach What are the more serious side effects of Tirzepatide
Updated for 2026 with CMS-0057-F rule, Medicare GLP-1 Bridge program, MFN pricing deals, oral Wegovy approval, and AHIP reform pledges